rzmmm

5 ms·

31.
by rzmmm 4mo ago
I think it's part of their marketing. Anthropic is not really ahead of other labs but these releases make it seem like they are reaching singularity
32.
by rzmmm 4mo ago
Seems to me this is more honest than the Mythos claims a while ago. too powerful to release publicly. Too expensive?
33.
by rzmmm 4mo ago
Prototyping is widely underappreciated. People think it's waste to throw away stuff but it's more costly to build upon shoddy foundations
34.
by rzmmm 4mo ago
Ocaml is probably closest to that. The ML language family has roots in generic code with global type inference.
35.
by rzmmm 4mo ago
The ranking is not comparable across time like that.
36.
by rzmmm 4mo ago
I was thinking maybe the author really likes Datadog MCP or has some kind of conflict of interest. It's weird to see this content in HN.
37.
by rzmmm 4mo ago
Maybe not. Sqlite has some kind of hand-written license-agreement waiver procedure.
38.
by rzmmm 4mo ago
I'm not sure if the authors means "ai engineer" like that.
39.
by rzmmm 4mo ago
Theoretically it mandates that derivative works use same license but it's unclear if that applies to LLM outputs.
40.
by rzmmm 5mo ago
> jumping back and forth between companies There is currently quite strong incentive to establish vendor lock-in for Anthropic and OpenAI. I see the ability to jump between companies quite important, especially for larger users. Right no
41.
by rzmmm 5mo ago
FYI many of the tsz sound mode features are available as linter plugins for typescript. They leverage type information
42.
by rzmmm 5mo ago
Let's start with laws which mandates that copyleft in LLM inputs transfer to LLM outputs
43.
by rzmmm 5mo ago
My guess is just open source maintainers trying out new genAI tools out of curiosity. Unintentional slopification
44.
by rzmmm 5mo ago
I have used AI agents extensively for coding and my experience is that it's fine for prototypes, but in large projects like this there is risk that the codebase becomes unmaintainable.
45.
by rzmmm 5mo ago
> The entire system also runs locally. I think approaches like this don't need to run other than locally. Maybe integrated as pre-push hook. The system is nondeterministic, so it's at odds with the purpose of CI.
46.
by rzmmm 5mo ago
Most likely not. There are some ad hoc countermeasures by Anthropic but the real solution is sandboxing
47.
by rzmmm 5mo ago
Red-teaming for the greater good.
48.
by rzmmm 5mo ago
I still use LLM in quite similar way as when ChatGPT was launched. There has been progress but I think the real leap was 2020-2022.
49.
by rzmmm 5mo ago
I've been observing something which sounds very similar.
50.
by rzmmm 5mo ago
I see it similarly. Companies have varying time preferences over short-term success vs. long-term success.
51.
by rzmmm 5mo ago
Or average joe becomes DIY plumber with help of chatGPT and there is a lot less demand for plumbers then.
52.
by rzmmm 5mo ago
In my projects I use /codegen and /llm directories. All regular generated (such as sqlc) code goes in /codegen and LLM-generated code in /llm.
53.
by rzmmm 5mo ago
It's like reading the Mythos preview card. He talks like their AI is some sci-fi monster. Curl developer put it well: "Mythos was mostly marketing"
54.
by rzmmm 5mo ago
It works fine if JavaScript is not enabled
55.
by rzmmm 5mo ago
Seems that in some online circles it has racist connotation which I was not aware. Some context https://web.archive.org/web/20260101134925/https://www.wired...
56.
by rzmmm 5mo ago
Maybe after decades. 2022 models were microscopic compared to latest models.
57.
by rzmmm 5mo ago
Checked all five except "caring for my horse" is "tinkering with my bicycle".
58.
by rzmmm 5mo ago
Needs an anti-anti-fraud service which terminates malfunctioning anti-fraud services.
59.
by rzmmm 5mo ago
It's a bit speculative. They need placebo-controlled trials and so far the results have not been very convincing for many psychiatric outcomes. There is exciting research around gut microbiota, but many of these studies which make roun
60.
by rzmmm 5mo ago
Looks like this is the placebo-controlled trial https://clinicaltrials.gov/study/NCT03408886 I can't find full analysis but the primary autism-symptom outcome improved by 9% in treatment group and 4% in controls.

More ›